BAXTER 0.15% POTASSIUM CHLORIDE AND 0.225% SODIUM CHLORIDE AND 3.75% GLUCOSE 500mL injection BP Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.15% potassium chloride and 0.225% sodium chloride and 3.75% glucose 500ml injection bp

baxter healthcare pty ltd - glucose, quantity: 37.5 g/l; sodium chloride, quantity: 2.25 g/l; potassium chloride, quantity: 1.5 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the potassium chloride ( 0.15%) and sodium chloride (0.225 %) and glucose (3.75 %) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.18% SODIUM CHLORIDE and 4% GLUCOSE 1000mL injection AHB1254 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.18% sodium chloride and 4% glucose 1000ml injection ahb1254

baxter healthcare pty ltd - glucose, quantity: 40 g/l; sodium chloride, quantity: 1.8 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.3% SODIUM CHLORIDE and 3.3% GLUCOSE 1000mL injection AHB1034 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.3% sodium chloride and 3.3% glucose 1000ml injection ahb1034

baxter healthcare pty ltd - glucose, quantity: 33 g/l; sodium chloride, quantity: 3 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.18% SODIUM CHLORIDE and 4% GLUCOSE 500mL injection AHB1253 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.18% sodium chloride and 4% glucose 500ml injection ahb1253

baxter healthcare pty ltd - glucose, quantity: 40 g/l; sodium chloride, quantity: 1.8 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.225% SODIUM CHLORIDE and 3.75% GLUCOSE 500mL Injection BP AHB1243 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.225% sodium chloride and 3.75% glucose 500ml injection bp ahb1243

baxter healthcare pty ltd - glucose, quantity: 37.5 g/l; sodium chloride, quantity: 2.25 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.3% SODIUM CHLORIDE and 3.3% GLUCOSE 500mL injection AHB1033 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.3% sodium chloride and 3.3% glucose 500ml injection ahb1033

baxter healthcare pty ltd - glucose, quantity: 33 g/l; sodium chloride, quantity: 3 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.45% SODIUM CHLORIDE and 2.5% GLUCOSE 500mL injection AHB1023 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.45% sodium chloride and 2.5% glucose 500ml injection ahb1023

baxter healthcare pty ltd - glucose, quantity: 25 g/l; sodium chloride, quantity: 4.5 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.244% POTASSIUM CHLORIDE and 0.18% SODIUM CHLORIDE and 4% GLUCOSE 1000mL injection AHB1224 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.244% potassium chloride and 0.18% sodium chloride and 4% glucose 1000ml injection ahb1224

baxter healthcare pty ltd - glucose, quantity: 40 g/l; potassium chloride, quantity: 2.24 g/l; sodium chloride, quantity: 1.8 g/l - injection, solution - excipient ingredients: water for injections - the potassium chloride (0.224%), sodium chloride (0.18%), and glucose (4%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Pfizer (Australia) GLUCOSE INTRAVENOUS INFUSION BP 5% glucose (as monohydrate) 5g/100 mL injection for infusion vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer (australia) glucose intravenous infusion bp 5% glucose (as monohydrate) 5g/100 ml injection for infusion vial

pfizer australia pty ltd - glucose monohydrate, quantity: 54.99 mg/ml (equivalent: glucose, qty 50 mg/ml) - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 31 july 2000: for fluid and carbohydrate depletion wherever a non-electrolyte fluid is required. in the treatment of hypoglycaemia. in the treatment of acute diarrhoeal disease. as a vehicle for the administration of other medications.

ASTRAZENECA GLUCOSE 10% w/v 1g/10mL injection BP ampoule Australia - engelsk - Department of Health (Therapeutic Goods Administration)

astrazeneca glucose 10% w/v 1g/10ml injection bp ampoule

phebra pty ltd - glucose, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium bicarbonate; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 12 august 2003: glucose injection bp 10% is used in the treatment of carbohydrate and fluid depletion. glucose is the preferred source of carbohydrate in parenteral nutrition regimes, and is used in the treatment of dehydration due to acute diarrhoeal disease. glucose injection bp 10% is used in preference to the 5% solution to provide adequate calories in a minimal volume of water and glucose injection bp 10% may also be used to treat hypoglycaemia.